Diversity of the V3 region of HIV in Paris, France. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Diversity of the V3 region of HIV in Paris, France.

AIDS. 1993 Sep;7(9):1199-204. Unique Identifier : AIDSLINE MED/94030750
Chaix ML; Chappey C; Couillin I; Rozenbaum W; Levy JP; Saragosti S; ICGM, INSERM U363, Hopital Cochin, Paris, France.

Abstract: OBJECTIVE: To carry out, within France, a large-scale molecular epidemiological investigation on the principal neutralizing determinant of HIV-1, located in the third variable region (V3) of the envelope protein. Such investigations are of the utmost importance in the identification and monitoring of the distribution and spread of different viral strains internationally. DESIGN: Using polymerase chain reaction (PCR), we examined the genetic variation of the V3 region sequences of 28 HIV-infected patients from Paris, France. RESULTS: Comparison of the Parisian V3 loop sequences with other published data indicates that the range of diversity in France is included within that of a large group that contains sequences from North America, the rest of Europe, Japan, India and Africa. Variability appears to be lower in the V3 loop than in its flanking regions. Five out of the six putative N-linked glycosylation sites show preferential alterations to charged amino acids. We report two motifs at the tip of the loop that have not been described previously. CONCLUSIONS: The structural homogeneity and the wide geographic representation of the major V3 group suggests that a common strategy could be applied to a large proportion of isolates in the development of a broad-spectrum HIV vaccine.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/*MICROBIOLOGY Amino Acid Sequence Base Sequence DNA Primers Glycosylation Human HIV Envelope Protein gp120/CLASSIFICATION/*GENETICS HIV-1/*GENETICS Molecular Sequence Data Paris/EPIDEMIOLOGY Peptide Fragments/CLASSIFICATION/*GENETICS Polymerase Chain Reaction Sequence Homology, Amino Acid Support, Non-U.S. Gov't Variation (Genetics) JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/epidemiology/KWDmicrobiologyaminoacidsequencebasesequencednaprimersglycosylationhumanhivenvelopeproteingp120/classification/KWDgeneticshiv-1/KWDgeneticsmolecularsequencedataparis/epidemiologypeptidefragments/classification/KWDgeneticspolymerasechainreactionsequencehomology,aminoacidsupport,non-uKWDsKWDgov'tvariation(genetics)journalarticle
940228
M9420771

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .